Drug Database
Back to search

Switzerland· 54637136

Accupaque

A iohexol product containing iodum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC V08AB02

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAccupaqueATCV08AB02REGISTER NO.54637136PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iodumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iohexol is registered in 17 of 19 countries.

Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose
Search iohexol products by name

Iohexol · ATC V08AB02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
iodum
Manufacturer
—
Country
Switzerland (CH)
ATC code
V08AB02
ATC class
Iohexol
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680546371364
    Plast Fl 50 ml
    CHF 51.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

353 interactions on record for iohexol.

Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iohexol against other medicinesHow interaction checks work

Iohexol · interactions on record

353 records

  • 286 severe
  • 54 moderate
  • 13 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ThiethylperazinA04AB03severe
  • TriflupromazinA04AD06severe
  • DronabinolA04AD10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iohexol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iohexol products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Bulgaria · Етанолов Разтвор На Йод Bt, Етанолов Разтвор На Йод Купро
  • Czechia · Lipiodol Ultra Fluide
  • Germany · Iod Caelo
  • Denmark · Omnipaque
  • Estonia · Iodine Valentis, Solutio Iodi Spirituosa
  • Spain · Tintura De Yodo Laboratorios Reig Jofré S.A.
  • Greece · Βαμμα Ιωδιου Mediplants, Βαμμα Ιωδιου Ζαρμπη
  • Croatia · Jod B. Braun
  • Lithuania · Jodas Bp, Jodas Valentis
  • Latvia · Joda Šķīdums Valentis, Joda Spirta Šķīdums
  • Poland · Jodid, Jodyna

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2130691-ee96-49cf-b6ed-e6693c683fca
GET /v1/drugs/e2130691-ee96-49cf-b6ed-e6693c683fca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "iohexolum 647 mg",
  "valid_from": "2009-04-01",
  "limitations": null,
  "galenic_form": "Inj Lös 300 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2009-04-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about iohexol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console